Prostate Cancer ADT Found to Increase Depression Risk
Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.
All articles by John Schieszer
Adjuvant Docetaxel Possibly Beneficial in High-Risk Prostate Cancer
In a study, adding docetaxel to androgen deprivation and radiation therapy for selected men with high-risk localized prostate cancer improved overall and metastasis-free survival.
Bladder Cancer Surgery Delay Increases Death Risk
Patients who undergo radical cystectomy for MIBC more than 12 weeks from diagnosis are at increased risk of death, regardless of whether they receive neoadjuvant chemotherapy.
Drug Treats Hyperphosphatemia Without Binding Phosphate
In a phase 3 trial, tenapanor, which reduces paracellular phosphate transport in the intestine, lowered elevated serum phosphorus in patients on hemodialysis.
Hyperkalemia Events Common With RAAS Inhibitor Use in CKD
Almost half of incident hyperkalemia events are followed by changes in RAAS inhibitor therapy.
BPH Prostatic Artery Embolization Facilitated With MR Angiography
Improved visualization of prostatic arteries shortens procedure time and decreases radiation exposure, new findings suggest.
Obstructive Sleep Apnea Treatment May Slow CKD Progression
In a study, CKD patients with OSA treated with nasal continuous positive airway pressure (CPAP) had significantly higher eGFR after 12 months of treatment than those not receiving CPAP.
Intense ADT Prior to RP May Improve Outcomes in Locally Advanced PCa
A phase 2 study demonstrated higher rates of pathologic complete response or minimal residual disease.
Best Ways to Estimate GFR in Potential Living Kidney Donors Identified
If direct measurements of glomerular filtration rate (GFR) cannot be obtained, the CKD-EPI and FAS equations should be preferred to estimate GFR, investigators concluded.
Hepcidin May Enable Early Ruling Out of Contrast-Induced AKI
Serum hepcidin rises significantly as early as 4 and 8 hours after percutaneous coronary intervention.
Next post in Acute Kidney Injury
